Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Edgerton

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Cancer Research|January 25, 2005
Perinucleolar compartment prevalence has an independent prognostic value for breast cancerRajesh V Kamath, Ann D Thor, Chen Wang, et al.
Oncotarget|February 25, 2016
Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancersHamid H Gari, Christy M Gearheart, Susan Fosmire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2020
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast CancersReema S Wahdan-Alaswad, Susan M Edgerton, Hiba Salem, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2025
SCoTCH-seq reveals that 5-hydroxymethylcytosine encodes regulatory information across DNA strandsJack S Hardwick, Somdutta Dhir, Angie Kirchner, et al.
JACC. Cardiovascular Imaging|September 18, 2010
Relationship between previous training and experience and results of the certification examination in cardiovascular computed tomographyAllen J Taylor, Jonathan Patrick, Suhny Abbara, et al.
Frontiers in Oncology|November 23, 2017
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain MetastasesMaría J Contreras-Zárate, D Ryan Ormond, Austin E Gillen, et al.
Hormones & Cancer|July 26, 2017
The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast CancerElizabeth A Wellberg, L Allyson Checkley, Erin D Giles, et al.
Breast Cancer Research : BCR|January 24, 2014
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamideDawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, et al.
JCI Insight|July 27, 2018
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivationElizabeth A Wellberg, Peter Kabos, Austin E Gillen, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Cancer Research|January 25, 2005
Perinucleolar compartment prevalence has an independent prognostic value for breast cancerRajesh V Kamath, Ann D Thor, Chen Wang, et al.
Oncotarget|February 25, 2016
Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancersHamid H Gari, Christy M Gearheart, Susan Fosmire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2020
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast CancersReema S Wahdan-Alaswad, Susan M Edgerton, Hiba Salem, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2025
SCoTCH-seq reveals that 5-hydroxymethylcytosine encodes regulatory information across DNA strandsJack S Hardwick, Somdutta Dhir, Angie Kirchner, et al.
JACC. Cardiovascular Imaging|September 18, 2010
Relationship between previous training and experience and results of the certification examination in cardiovascular computed tomographyAllen J Taylor, Jonathan Patrick, Suhny Abbara, et al.
Frontiers in Oncology|November 23, 2017
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain MetastasesMaría J Contreras-Zárate, D Ryan Ormond, Austin E Gillen, et al.
Hormones & Cancer|July 26, 2017
The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast CancerElizabeth A Wellberg, L Allyson Checkley, Erin D Giles, et al.
Breast Cancer Research : BCR|January 24, 2014
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamideDawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, et al.
JCI Insight|July 27, 2018
FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivationElizabeth A Wellberg, Peter Kabos, Austin E Gillen, et al.
Pageof 9